By Michele Maatouk
Date: Wednesday 11 Feb 2026
(Sharecast News) - Oxford Biomedica said on Wednesday that the deadline for EQT to make a formal takeover bid has been extended amid ongoing preliminary discussions.
| China's CDE accepts GSK's regulatory filing for ... | 10-Feb-2026 | ShareCast |
| Annual sales, profits jump at AstraZeneca | 10-Feb-2026 | ShareCast |
| JP Morgan raises target price on GSK | 09-Feb-2026 | ShareCast |
| Avacta finds new science chief internally | 09-Feb-2026 | ShareCast |
| Director dealings: GSK chairman raises stake | 06-Feb-2026 | ShareCast |
| Director/PDMR Shareholding | 12-Feb-2026 | 09:00 | RNS |
| Correction: c.£1.5 million Contract Extension | 12-Feb-2026 | 08:48 | RNS |
| Form 8.5 (EPT/RI) - Oxford Biomedica plc | 12-Feb-2026 | 07:46 | RNS |
| Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc | 12-Feb-2026 | 07:42 | RNS |
| Director/PDMR Share Purchase | 12-Feb-2026 | 07:01 | RNS |
| Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
| Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
| Investment Column:BTG | 06-Oct-2011 | The Independent |
| Investment Column:Genus | 09-Sep-2011 | The Independent |
| Questor :Dechra Pharmaceuticals | 08-Sep-2011 | Telegraph |
| Price | 28,194.18 |
| Closing Price Change | 768.15 |
| % Change | 2.80 % |
| 11-Feb-26 Close | 28,194.18 |
You are here: research